| Literature DB >> 35351944 |
Alicja Karolina Surowiak1, Marta Sowała1, Michał Talma2, Katarzyna Groborz1, Lucyna Balcerzak1, Stanisław Lochyński1,3, Daniel Jan Strub4,5.
Abstract
Due to market and legislative expectations, there is a constant need to explore new potential antimicrobial agents for functional perfumery. In this study, we evaluated the antimicrobial activity of 53 low molecular oximes and the corresponding carbonyl compounds against Escherichia coli, Enterococcus hirae, Pseudomonas aeruginosa, Bacillus cereus, Staphylococcus aureus, Aspergillus brasiliensis, Legionella pneumophila and Candida albicans. The most potent compound was α-isomethylionone oxime, which exhibited a minimum inhibitory concentration (MIC) of 18.75 µg/mL against E. hirae. The evaluation of the MICs for bacterial and fungal strains was performed for selected compounds, for example, the MIC of 2-phenylpropionaldehyde, cis-jasmone oxime, and trans-cinnamaldehyde measured against A. brasiliensis was 37.50 µg/mL. ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) cell viability assays were performed to assess the cytotoxicity of tested compounds. ADME-Tox indicated the safety and promising properties of selected compounds, which enables their usage as nontoxic supporting antibacterial agents. The results of the in vitro MTS assay were consistent with the ADME-Tox results. None of the compounds tested was toxic to Human Embryonic Kidney 293T (HEK293T) cells, with all cell viabilities exceeding 85%.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35351944 PMCID: PMC8964709 DOI: 10.1038/s41598-022-09210-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Properties of ADME-Tox for the selected compounds with the lowest MIC.
| Compound | MW | SASA | donorHB | accptHB | QPlogPo/w | QPlogHERG | QPPCaco | QPlogBB | QPPMDCK |
|---|---|---|---|---|---|---|---|---|---|
| α-Isomethylionone oxime | 221 | 488 | 1.00 | 2.70 | 2.98 | − 3.34 | 2040 | − 0.35 | 1070 |
| Pseudoionone oxime | 207 | 540 | 1.00 | 2.70 | 3.25 | − 4.50 | 1840 | − 0.66 | 958 |
| β-Ionone oxime | 207 | 501 | 1.00 | 2.70 | 2.82 | − 3.86 | 2000 | − 0.40 | 1040 |
| 147 | 378 | 1.00 | 3.20 | 1.29 | − 4.43 | 1320 | − 0.51 | 668 | |
| 2-Phenylpropionaldehyde | 134 | 356 | 0.00 | 2.00 | 1.87 | − 3.68 | 2570 | − 0.04 | 1370 |
| α-Hexylcinnamaldehyde oxime | 231 | 565 | 1.00 | 3.20 | 3.52 | − 5.44 | 1830 | − 0.81 | 952 |
| 179 | 446 | 1.00 | 2.70 | 2.34 | − 3.56 | 2460 | − 0.28 | 1310 |
MW molecular weight, SASA total solvent-accessible surface area, donorHB estimated number of donated hydrogen bonds, accptHB estimated number of accepted hydrogen bonds, QPlogPo/w predicted octanol/water partition coefficient, QPpolrz predicted polarizability in cubic angstroms, QPlogPC16 predicted hexadecane/gas partition coefficient, QPlogPoct predicted octanol/gas partition coefficient, QPlogPw predicted water/gas partition coefficient, QPlogS predicted aqueous solubility, CIQPlogS conformation-independent predicted aqueous solubility, QPlogHERG predicted IC50 value for blockage of HERG K+ channels, QPPCaco predicted apparent Caco-2 cell permeability for non-active transport, QPlogBB predicted brain/blood partition coefficient, QPPMDCK− predicted apparent MDCK cell permeability for non-active transport, QPlogKp predicted skin permeability, QPlogKhsa prediction of binding to human serum albumin, Percent Human Oral Absorption predicted human oral absorption on 0–100% scale.
Figure 1Images of HEK293T cell lines from a Nikon Eclipse TS2R microscope. (A) Control well. With added tested agents: (B) Propiophenone oxime, (C) β-ionone oxime, (D) (+)-carvone oxime, and E. norcamphor oxime. On comparison of the images, it can be stated that the tested compounds do not affect the morphology or viability of the cell line.
The percentage of viable HEK293T cells after 24 h of incubation with 25 µM of the indicated oxime. SD standard deviation.
| Oxime of | Viability % | SD | Error % | Control (viability %) |
|---|---|---|---|---|
| Propiophenone | 91.95 | 1.41 | 1.53 | 100.00 |
| β-Ionone | 100.00 | 5.30 | 5.30 | 100.00 |
| (+)-Carvone | 90.21 | 3.96 | 4.39 | 100.00 |
| Norcamphor | 93.46 | 4.61 | 4.94 | 100.00 |
The most relevant MIC values.
| Microorganism | Compound | MIC [mg/L] (mM) |
|---|---|---|
| (−)-Camphor | 75.50 (0.49) | |
| (−)-Camphor oxime | 150.00 (0.90) | |
| Ampicillin | 25.00 (0.07)[ | |
| Gentamicin | 20.00 (0.04)[ | |
| α-Ionone oxime | 112.50 (0.54) | |
| β-Ionone | 150.00 (0.78) | |
| β-Ionone oxime | 37.50 (0.18) | |
| Dihydro-α-ionone oxime | 150.00 (0.72) | |
| Dihydro-β-ionone | 300.00 (1.54) | |
| Dihydro-β-ionone oxime | 150.00 (0.72) | |
| β-Cyclocitral | 300.00 (1.97) | |
| Gentamicin | 0.39 (8.00 × 10−4)[ | |
| α-Amylcinnamaldehyde oxime | 150.00 (0.74) | |
| α-Hexylcinnamaldehyde oxime | 42.18 (0.18) | |
| 150.00 (1.11) | ||
| α-Isomethylionone oxime | 18.75 (0.08) | |
| Ciprofloxacin | 8.00 (0.02)[ | |
| Pseudoionone oxime | 150.00 (0.72) | |
| Gentamicin | 2.00 (4.00 × 10−3)[ | |
| Ampicillin | 1.00 (3.00 × 10−3)[ | |
| α-Hexylcinnamaldehyde | 225.00 (1.04) | |
| α-Hexylcinnamaldehyde oxime | 37.5. (0.16) | |
| Phenylacetaldehyde | 42.18 (0.35) | |
| β-Ionone oxime | 37.50 (0.18) | |
| Pseudoionone oxime | 37.50 (0.18) | |
| Safranal oxime | 150.00 (0.91) | |
| Geranyl acetone oxime | 150.00 (0.72) | |
| Ampicillin | 10.00 (0.03)[ | |
| Gentamicin | 5.00 (0.01)[ | |
| 112.50 (0.85) | ||
| 37.50 (0.25) | ||
| 2-Phenylpropionaldehyde | 37.50 (0.28) | |
| Piperonal | 112.50 (0.74) | |
| (±)-Citronellal oxime | 150.00 (0.89) | |
| 75.00 (0.45) | ||
| 37.50 (0.21) | ||
| Dihydrocinnamaldehyde oxime | 75.00 (0.50) | |
| Amphotericin B | 1.00 (1.00 × 10−3)[ | |
| 37.50 (0.28) | ||
| 75.00 (0.51) | ||
| Veratraldehyde | 150.00 (0.90) | |
| Ethylvanillin | 150.00 (0.90) | |
| Pseudoionone | 112.50 (0.58) | |
| Pseudoionone oxime | 37.50 (0.18) | |
| (−)-Carvone | 112.50 (0.74) | |
| (−)-Carvone oxime | 225.00 (1.36) | |
| Amphotericin B | 1.00 (1.00 × 10−3)[ | |
| Fluconazole | 1.00 (3.00 × 10−3)[ | |
| Miconazole | 2.00 (5.00 × 10−3)[ |
Figure 2Graph showing the calculated parameters related to the biopermeability of compounds for humans: QPlogKp (predicted skin permeability, log Kp.), QPlogKhsa (prediction of binding to human serum albumin). The green area shows the normal range of values.